This observation proved the significance of the Vascular Endothelial Growth Factor A (VEGFA)-VEGFR2 signaling pathway in GBM progression, which was highlighted in the GGEP enrichment analysis (Fig. 2B), and thus targeting this pathway provides a promising research direction in the development of GBM treatment strategies. This evidence concerns the gene KDR and glioblastoma.